Transforming Healthcare Intelligence

Trusted by leading pharmaceutical and healthcare organisations, Clinithink’s proven AI technology extracts precise insights from complex unstructured healthcare data, with exceptional accuracy and provenance, to deliver meaningful clinical and financial impact.

AI for

Life
Sciences

Leverage the power of real-world data in clinical narrative to rapidly identify and better understand specific patient cohorts, in just hours or days - not months or years.

AI for

Population
Health

Enhance clinical productivity and improve population health outcomes by identifying risks, detecting rare diseases and tracking disease progression.

AI for

Revenue

Cycle

Improve accounts receivable performance through automated documentation analysis. Help reduce denials, ensure optimized coding and increase the number of successful appeals.

Patented CNLP technology that's helping solve some of the most complex challenges in healthcare today.

Clinithink is a technology company built around CLiX®, the world’s first Healthcare AI capable of truly understanding unstructured medical notes, leveraging the unique advantages of SNOMED CT ontology.

CLiX can read, understand and extrapolate from the meandering mass of deductions, hunches, opinions and observations that healthcare professionals use to describe conditions in real-world settings. CLiX can also recognise idioms, metaphors, turns of phrase, and all 72 different ways of saying ‘fractured left neck of femur’.

CLiX is capable of understanding a vast quantity of unique and detailed clinical concepts such as; certainty, severity, laterality and temporality. It is able to do this by mapping the data it ‘reads’ and comparing it to the structured clinical vocabulary of SNOMED clinical terms.

By utilising the power of CLiX technology, pharmaceutical and healthcare organisations can create rich and structured meaning from the unstructured narrative within a patient’s electronic medical record (EMR), to help accelerate the early diagnosis of cancer and chronic diseases, increase the efficiency of clinical trials and improve reimbursement performance.

Latest news and information

Stay up to date with all the latest news and insights from Clinithink.

Research study presented at ASCO demonstrates how Clinithink’s AI technology can predict risk of lung cancer at an earlier stage
Research study presented at ASCO demonstrates how Clinithink’s AI technology can predict risk of lung cancer at an earlier stage
Clinithink secures investment as Development Bank targets growth in healthcare AI technology
Clinithink secures investment as Development Bank targets growth in healthcare AI technology
Clinithink appoints Mark Johnston as Chief Executive Officer
Clinithink appoints Mark Johnston as Chief Executive Officer